KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Revenue: 2017-2024

Historic Revenue for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to $1.0 million.

  • Aquestive Therapeutics' Revenue fell 5.43% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.2 million, marking a year-over-year decrease of 122.34%. This contributed to the annual value of $1.0 million for FY2024, which is 98.01% down from last year.
  • According to the latest figures from FY2024, Aquestive Therapeutics' Revenue is $1.0 million, which was down 98.01% from $50.6 million recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Revenue registered a high of $50.8 million during FY2021, and its lowest value of $1.0 million during FY2024.
  • In the last 3 years, Aquestive Therapeutics' Revenue had a median value of $47.7 million in 2022 and averaged $33.1 million.
  • Per our database at Business Quant, Aquestive Therapeutics' Revenue surged by 1,170.80% in 2021 and then crashed by 98.01% in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Revenue stood at $4.0 million in 2020, then soared by 1,170.80% to $50.8 million in 2021, then decreased by 6.20% to $47.7 million in 2022, then rose by 6.09% to $50.6 million in 2023, then tumbled by 98.01% to $1.0 million in 2024.